Krakauer R S, Sundeen J, Sauder D N, Scherbel A
Arch Dermatol. 1981 Feb;117(2):80-2.
We investigated immunoregulatory function in patients with progressive systemic sclerosis (PSS) in terms of in vitro IgM synthesis. Suppressor-cell function seems normal in regard to the ability of concanavalin A-treated cells to inhibit IgM synthesis by normal cells. At 4 x 10(5) T cells to 3 x 10(5) allogeneic normal B cells per milliliter, T cells from patients with PSS induce significantly more IgM synthesis by normal B cells than do normal T cells. This increased helper T-cell function might be involved in the pathogenesis of the disease.
我们从体外IgM合成方面研究了进行性系统性硬化症(PSS)患者的免疫调节功能。就伴刀豆球蛋白A处理的细胞抑制正常细胞IgM合成的能力而言,抑制细胞功能似乎正常。在每毫升4×10⁵个T细胞与3×10⁵个同种异体正常B细胞的条件下,PSS患者的T细胞比正常T细胞能诱导正常B细胞合成显著更多的IgM。这种辅助性T细胞功能的增强可能参与了该疾病的发病机制。